Navigation Links
InspireMD Reports Financial Results For Period Ended March 31, 2013
Date:5/8/2013

or the 1,114-patient trial, which will be conducted at 70 sites in the U.S. and Europe, will be Gregg Stone, MD, of the Cardiovascular Research Foundation in New York and Jose P.S. Henriques, MD, of the Academic Medical Center Amsterdam in The Netherlands.

Upcoming EventsInspireMD will host a symposium with key opinion leaders to review six month follow up data from the Company's multi-center MASTER trial of the MGuard Embolic Protection Stent.  The meeting will take place at the EuroPCR meeting in Paris, France on Thursday, May 23rd at 12:00pm Paris time. 

About Stenting and MGuard™ EPS™Standard stents were not engineered for heart attack patients. They were designed for treating stable angina patients whose occlusion is different from that of an occlusion in a heart attack patient.

In acute heart attack patients, the plaque or thrombus is unstable and often breaks up as the stent is implanted causing downstream blockages (some of which can be fatal) in a significant portion of heart attack patients.

The MGuard EPS is integrated with a precisely engineered micro net mesh that prevents the unstable arterial plaque and thrombus (clots) that caused the heart attack blockage from breaking off.

While offering superior performance relative to standard stents in STEMI patients with regard to ST segment resolution, the MGuard EPS requires no change in current physician practice - an important factor in promoting acceptance and general use in time-critical emergency settings.

About InspireMD, Inc.InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the NYSE MKT under the ticker symbol NSPR.

MGuard EPS is CE Mark approved. It is not approved for sale in the
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. InspireMD Receives Approval From US Food and Drug Administration to Begin US Regulatory Trial
2. InspireMD Closes $25 Million Underwritten Public Offering
3. InspireMD Announces Pricing of Underwritten Public Offering of Common Stock and Listing on NYSE MKT
4. InspireMD Receives CE Mark Approval for Carotid Embolic Protection Stent
5. InspireMD Files Amended Registration Statement for Proposed Public Offering of Common Stock
6. InspireMD Reports Results for Period Ended Dec. 31, 2012
7. InspireMD to Discuss MGuard(TM) and the MASTER Randomized Trial Results at the ICI 2012 Meeting
8. Positive Results of InspireMDs MASTER Trial to be Published on November 6 in Journal of American College of Cardiology
9. InspireMD Reports Results For Period Ending Sept. 30, 2012
10. InspireMD Announces Positive Results From MGuard(TM) Stent MASTER Trial for Emergency Treatment of Heart Attack Patients
11. InspireMD to Present at Harvard Investors Group on June 27 in New York
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... June 29, 2015 According to a ... Microwave, Cryoablation, IRE, Ultrasound), Mode of treatment (Surgical, Laparoscopic, Percutaneous), ... Forecasts to 2020", published by MarketsandMarkets, the global Tumor Ablation ... at a CAGR of 11.5% from 2015 to 2020. ... 86 F igures spread through 330 ...
(Date:6/29/2015)... Md. , June 29, 2015 The ... New Jersey Board of Professional ... a provider of courses to professional engineers for continuing ... accreditation further demonstrates the value and quality of PDA,s ... . "Our lecture courses and hands-on professional training at ...
(Date:6/29/2015)... 29, 2015  VisionCare Ophthalmic Technologies, Inc. ... devices for the treatment of age-related macular ... "Long-Term (60-month) Results for the Implantable Miniature ... Age in Patients with End-Stage Age-Related Macular ... 5-year data show substantial retention of gains ...
Breaking Medicine Technology:Tumor Ablation Market Worth $515.2 Million by 2020 2Tumor Ablation Market Worth $515.2 Million by 2020 3Tumor Ablation Market Worth $515.2 Million by 2020 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 2Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 3Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 4Five-Year Data Demonstrates Long Term Effectiveness and Safety of VisionCare's Telescope Implant for Macular Degeneration in Patients 65 Years and Older 5
... Dec. 21, 2011  In a move aimed at bolstering current ... Hospital Boston have created a new method that combines multiple ... Unlike current approaches, which rely on detecting evidence of drug ... this new method may be able to identify issues years ...
... 2011 Despite the numerous medical advances that happen ... States is still higher than most European countries.  While ... rate of pre-term births, researchers are committed to finding ... Medicine ® researchers are examining a new ...
Cached Medicine Technology:Taking a Predictive Approach to Identifying Adverse Drug Reactions 2Taking a Predictive Approach to Identifying Adverse Drug Reactions 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 2Northwestern Researchers Trial New Device that May Support Improved Newborn Health 3Northwestern Researchers Trial New Device that May Support Improved Newborn Health 4
(Date:6/29/2015)... , ... June 29, 2015 , ... ... C. Cook, to its multidisciplinary group of physicians and specialists. Dr. Cook is ... provide quality healthcare in hopes of achieving outstanding medical outcomes. , “We are ...
(Date:6/29/2015)... ... June 29, 2015 , ... The Society for Immunotherapy of ... has granted accelerated approval of Bristol-Myers Squibb’s Opdivo® (nivolumab) for the treatment of ... approval of nivolumab for patients with metastatic melanoma in Europe represents a major ...
(Date:6/29/2015)... ... June 29, 2015 , ... ... contractors, nonprofits, independent schools, and other growing businesses across the United States, has ... Value Added Resellers for the fifth consecutive year. , Based on company revenue ...
(Date:6/29/2015)... ... ... the country give their coworkers and families gifts all the time. From holiday exchanges to ... do coworkers donate “life” to the husband of a coworker? For one VA employee, the ... me her husband was on a donor list,” Glenshaw resident Kathi Dahl said. “I just ...
(Date:6/29/2015)... ... 2015 , ... Assurex Health, a precision medicine company providing ... pain conditions, has announced appointments to three key leadership roles, according to Virginia ... President, Chief Financial Officer; Craig S. Lewis, Senior Vice President, Chief Marketing and ...
Breaking Medicine News(10 mins):Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 2Health News:Healthpointe in La Tijera Proudly Announces the Addition of a New Chiropractor 3Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 2Health News:Society for Immunotherapy of Cancer Reacts to EMA Approval of Nivolumab for Treatment of Metastatic Melanoma 3Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 2Health News:Brittenford Systems Celebrates Fifth Consecutive Year on Bob Scott Insights Top 100 VARs 3Health News:VA Pittsburgh Employee Donates Kidney to Coworker’s Spouse 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 2Health News:Assurex Health Names Executives to Posts as CFO, CMO and VP/Clinical Operations 3
... "They said one pink,bus couldn,t change a ... for,Breast Health Education,s message on the side of ... starting next week. The bus will promote the,"Size ... http://www.newscom.com/cgi-bin/prnh/20081028/DC42054 ), October is National ...
... Leverages the Adify Platform to Aggregate Leading Sites ... Boomers Caring for Aging Parents, SAN MATEO, ... comprehensive online resource for people caring,for aging loved ... the first vertical ad,network to reach baby boomers ...
... SAUDE) announces the following webcast:, What: Medial Saude ... November 6, 2008 @ 10:00 AM EST, Where: http://prnewswire.isat.com.br/?palestra_id=422 ... http://prnewswire.isat.com.br/?palestra_id=421 (in Portuguese), How: Live over ... address above., ...
... Brain-Active: It,s National Alzheimer,s Disease Awareness Month, SANTA ... or lose it, is a,phrase originally coined to express ... valid when applied to brain fitness. Numerous studies,have shown ... as,neurobics in some circles -- can help stave off ...
... Strategy of Home Telehealth for the Management of Heart Failure" ... ... October 28, 2008 -- American TeleCare, Inc. (ATI), the leader ... telehealth solutions, announced that its InLife™ and LifeView™ Telehealth Systems ...
... Surgeons Annual Meeting, CHICAGO, Oct. 28 ... rare congenital deformity who turned her,differences into a ... of,the 2008 Patients of Courage: Triumph Over Adversity ... Plastic Surgery 2008 conference,Saturday, November 1, in Chicago., ...
Cached Medicine News:Health News:The Maurer Foundation Promotes Breast Health Message With Unique Traveling Pink Bus 2Health News:Caring.com Launches First Ad Network to Reach Family Caregivers 2Health News:Webcast Alert: Medial Saude S/A Announces Third Quarter 2008 Earnings Conference Call Webcast 2Health News:10 Surprising Facts About Using Brain Training to Fight Dementia 2Health News:10 Surprising Facts About Using Brain Training to Fight Dementia 3Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 2Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 3Health News:Telehealth Solutions from American TeleCare, Inc. Support Heart Failure Management Study in Canada 4Health News:Towson Student Wins Courage Award, Turns Facial Differences Into Positive Tool 2
... by seeing more patients per day. Utilizing the ... a 14-18 patients per day practice into a ... test sequences, youll perform accurate refractions in less ... making it easy to delegate tasks to office ...
... web-based application for secure access to ... reporting system. It is highly user ... comprehensive analysis, and professional reporting from ... with HIPAA requirements, reports also include ...
... Nothing can be more frustrating to a ... section of tissue than using instruments that are ... simple, or more complex, we offer a wide ... From realigning and polishing the tips to standard ...
... We repair most Olympus fiber and ... and intubation scopes used in OR and ... all repairs meet or exceed the standards ... with a 120-day warranty against defects in ...
Medicine Products: